How to Make Friends and Innovate: Using Social Networks to Transform Innovation in Health Care
Tags: physician social networks, patient social networks, Social BusinessAt this year’s forthcoming HBA Leadership Conference being held in Washington, DC, we will explore how social business tools are being used to drive innovation throughout the healthcare industry. From medical education and clinical trial development to clinical research and disease management, our panel will share specific examples and key learnings needed to accelerate the adoption and use of the right social strategy and tools.
Read more » « CollapsePhysicians Increase Use of Social Tools
Tags: social media, Facebook, physician social networks, physicians, researchTwo recent surveys explore how physician’s use social media for personal and professional use. What was interesting from the data is how actively physicians are now using social tools for professional purposes, particularly their affinity for closed, private communities.
Read more » « CollapseBIO International: Social Networks in Life Science
Tags: ozmosis, BioPharma, life sciences, physician social networks, patient communities, Deloitte, sermoOn the heels of releasing its latest findings on the use of social networks in the life sciences industry, Deloitte Research has invited Ozmosis to join its BIO International 2011 presentation and panel discussion on "Improving Innovation Through Use of Social Networks" Thursday, June 29th in Washington, DC.
Read more » « CollapseHow Social Networking Has Changed Business
Tags: ozmosis, clinical insights, healthcare, Facebook, physician social networks, IBM The Harvard Business Review recently featured a post from Bill George, a Professor of Management Practice at Harvard Business School, where he states, “Social networking is the most significant business development of 2010, topping the resurgence of the U.S. automobile industry.” As Bill points out, social networking took a transcendent leap forward in 2010 as it morphed from a "personal communications tool for young people into a new vehicle that business leaders are using to transform communications with their employees and customers".Read more » « Collapse
Social Networks for Life Sciences
Tags: physician social networks
Today, Deloitte Research released a new study on the use of social networks in the life sciences industry entitled, "To Friend or Not?"
Deloitte notes, "the industry thinks of social networks as marketing, similar to direct-to-consumer advertising; only more targeted. In reality, social networks are promising as tools that let the company collect information from, communicate to, and collaborate with people outside company walls."
Read more » « CollapseThe New Engagement Channel: Physician Networks
Tags: Pharma, Bayer Schering Pharma, physician social networks, physicians, engagementLen Starnes, the Head of Digital Marketing & Sales, General Medicine at Bayer Schering Pharma, has long been regarded as a thought leader and trailblazer among Pharma executives when it comes to effectively leveraging social media. He recently shared a fantastic article on the impact physician networks are having across the world and how Pharma is moving to actively engage providers through each network.
Read more » « CollapseUsing Social Media Platforms to Amplify Public Health Messaging
Tags: social media, Facebook, Twitter, physician social networks, Public Health Initiatives, ogilvy, georgetown, white paperOgilvy Washington and the Center for Social Impact Communication at Georgetown University have released a terrific white paper, “Using Social Media Platforms to Amplify Public Health Messaging” that explores how social marketers rely on networks such as Facebook, Twitter and Youtube as channels to raise awareness of public health-related issues, facilitate behavior change, and ultimately help people live healthier, safer lives.
Read more » « CollapseFDA Framework for Regulating Social Media Promotion
Tags: social media, BioPharma, Pharma, FDA, physician social networks
On March 16th, Ozmosis submitted its comment to the FDA's docket on the promotion of regulated medical products using the internet and social media, joining over 150 other submissions by drug manufacturers, health systems, consultants, agencies, advocacy groups, and private individuals. 
The level of interest in this subject should surprise no one.
The world of medicine has changed dramatically since the FDA's last hearings on internet use. In 1999, less than 50% of physicians used the internet for professional purposes. Today, Google reports that virtually all physicians (92%) use the internet to gather medical information in a clinical setting, and according to Manhattan Research, 89% of U.S. physicians now describe the web as "essential to their professional practice." With the groundswell for social media resources among physicians continuing to rise, Manhattan Research also shares that 71% of U.S. physicians are interested in or already use physician social networks for peer-to-peer interactions.
However, many pharmaceutical manufacturers hesitate to engage with physicians through social media due to the uncertain regulatory landscape. While there have been notable exceptions, as highlighted in our FDA comment, this missed opportunity is a detriment to patients, providers and manufacturers alike. We strongly encourage the FDA to provide clear guidance to avoid further delay.
So what would appropriate guidance for manufacturer participation look like? At Ozmosis, we have established a set of principles that, if applied to the broader web and social media landscape, would be to the benefit of manufacturers, physicians, and patients alike.
On Ozmosis, physicians use their real identities and share their professional affiliations, resulting in a more trusted and transparent exchange of clinical information. Since physicians always know with whom they are communicating and sharing knowledge, the insights and discussions that take place on Ozmosis are highly valued and insight rich. Any regulatory framework put forth must ensure the same level of trust, transparency and accountability our physicians already benefit from every day.
Read more » « Collapse
